AYN — Global Testing Income Statement
0.000.00%
Last trade - 00:00- SG$37.41m
- SG$10.84m
- $41.52m
- 95
- 90
- 86
- 100
Annual income statement for Global Testing, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 22.9 | 38.7 | 46.4 | 40.6 | 41.5 |
| Cost of Revenue | |||||
| Gross Profit | 3.8 | 12 | 16.2 | 7.94 | 9.42 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 22.3 | 30.9 | 34.2 | 36.7 | 36.1 |
| Operating Profit | 0.589 | 7.8 | 12.1 | 3.9 | 5.43 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 0.417 | 7.74 | 12.1 | 3.89 | 5.42 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 0.356 | 9.4 | 11.2 | 3.4 | 5.15 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 0.356 | 9.4 | 11.2 | 3.4 | 5.15 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 0.356 | 9.4 | 11.2 | 3.4 | 5.15 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.01 | 0.265 | 0.32 | 0.097 | 0.15 |
| Dividends per Share | |||||
| Special Dividends per Share |